This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Harmony Biosciences Management, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: The Innovative Contributions of Stephen V O'Quinn
Introduction
Stephen V O'Quinn is a notable inventor based in Wake Forest, NC (US). He has made significant strides in the field of medical treatments, particularly focusing on autism spectrum disorder (ASD). His work emphasizes the potential benefits of cannabidiol (CBD) in addressing behavioral symptoms associated with ASD.
Latest Patents
Stephen V O'Quinn holds a patent for the treatment of fragile X syndrome with cannabidiol. This innovative technology outlines a method for treating one or more behavioral symptoms of ASD by administering an effective amount of CBD. The findings suggest that subjects with moderate to severe ASD, who exhibit high levels of social avoidance and anxiety, may experience a reduction in irritability when treated with CBD.
Career Highlights
O'Quinn is currently associated with Harmony Biosciences Management, Inc., where he continues to explore advancements in medical treatments. His dedication to improving the lives of individuals with ASD is evident in his research and patent contributions.
Collaborations
Stephen has collaborated with professionals such as Joseph Palumbo and Terri Sebree, enhancing the impact of his work through shared expertise and insights.
Conclusion
Stephen V O'Quinn's innovative approach to treating ASD with cannabidiol showcases his commitment to advancing medical science. His contributions are paving the way for new treatment options that could significantly improve the quality of life for many individuals.